# Dose Optimization of MDMA-Assisted Therapy for PTSD

> **NCT06418178** · PHASE2 · RECRUITING · sponsor: **Bronx VA Medical Center** · enrollment: 60 (estimated)

## Conditions studied

- Posttraumatic Stress Disorder

## Interventions

- **DRUG:** Midomafetamine
- **BEHAVIORAL:** Psychotherapy

## Key facts

- **NCT ID:** NCT06418178
- **Lead sponsor:** Bronx VA Medical Center
- **Sponsor class:** FED
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-06-03
- **Primary completion:** 2029-10
- **Final completion:** 2029-10
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2025-06-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06418178

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06418178, "Dose Optimization of MDMA-Assisted Therapy for PTSD". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06418178. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*